Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A study of elective genome sequencing and pharmacogenetic testing in an unselected population.

Molecular genetics & genomic medicine - 1 Sept 2021

Cochran Meagan, East Kelly, Greve Veronica, Kelly Melissa, Kelley Whitley, Moore Troy, Myers Richard M, Odom Katherine, Schroeder Molly C, Bick David

Abstract excerpt

BACKGROUND: Genome sequencing (GS) of individuals without a medical indication, known as elective GS, is now available at a number of centers around the United States. Here we report the results of elective GS and pharmacogenetic panel testing in 52 individuals at a private genomics clinic in Alabama. METHODS: Individuals seeking elective genomic testing and pharmacogenetic testing were recruited through a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gene Frequency
Share to Genetic Testing

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Healthy Volunteers

Share to Pharmacogenomic Variants

Share to Phenotype

Share to Population

Share to Whole Genome Sequencing

Source

Open in PubMed Open full text

Identifiers

PMID: 34313030
DOI: 10.1002/mgg3.1766
PMCID: PMC8457704

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

A study of elective genome sequencing and pharmacogenetic testing in an unselected population.PMID 34313030Read ↗

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.Semantic proximity Read ↗

Genome Sequencing Enhances Precision and Clinical Utility of Pharmacogenetic Data Compared to Arrays.Semantic proximity Read ↗

The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations.Semantic proximity Read ↗

Mapping the incidentalome: estimating incidental findings generated through clinical pharmacogenomics testing.Semantic proximity Read ↗

Elective genomic sequencing for adults in research, clinical and commercial contextsSemantic proximity Read ↗

Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience.Semantic proximity Read ↗

Clinically relevant germline variants in allogeneic hematopoietic stem cell transplant recipientsSemantic proximity Read ↗

Genetic findings and health care utilization among individuals undergoing population genomic screening for actionable hereditary disorders.Semantic proximity Read ↗

Using germline genotype in cancer pharmacogenetic studies.Semantic proximity Read ↗

Identifying rare, medically relevant variation via population-based genomic screening in Alabama: opportunities and pitfalls.Semantic proximity Read ↗

Design and anticipated outcomes of the eMERGE-PGx project: a multicenter pilot for preemptive pharmacogenomics in electronic health record systems.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.